INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 302 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,459,327 | +276.9% | 199,255 | +363.3% | 0.01% | +300.0% |
Q1 2024 | $1,183,150 | -85.0% | 43,008 | -83.3% | 0.00% | -88.2% |
Q4 2023 | $7,864,194 | +22.2% | 257,927 | +26.8% | 0.02% | 0.0% |
Q3 2023 | $6,433,247 | +669.5% | 203,455 | +892.5% | 0.02% | +466.7% |
Q2 2023 | $835,990 | -86.2% | 20,500 | -87.4% | 0.00% | -96.7% |
Q1 2023 | $6,041,616 | +20.1% | 162,104 | +12.4% | 0.09% | -2.2% |
Q4 2022 | $5,031,975 | +206.3% | 144,224 | +391.2% | 0.09% | +187.5% |
Q3 2022 | $1,643,000 | -55.2% | 29,361 | -41.9% | 0.03% | -67.3% |
Q1 2022 | $3,671,000 | +321.0% | 50,521 | +585.1% | 0.10% | +263.0% |
Q4 2021 | $872,000 | +505.6% | 7,374 | -37.4% | 0.03% | -15.6% |
Q1 2020 | $144,000 | -69.6% | 11,785 | -63.5% | 0.03% | +6.7% |
Q4 2019 | $474,000 | +39.8% | 32,297 | +27.6% | 0.03% | +50.0% |
Q3 2019 | $339,000 | -13.7% | 25,321 | +5.5% | 0.02% | -53.5% |
Q2 2019 | $393,000 | -35.1% | 24,000 | -32.4% | 0.04% | -56.6% |
Q1 2019 | $606,000 | – | 35,500 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |